Hip Developmental DysplasiaNCT07002840
Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia
A study testing Cross- legged sitting position and Physical Therapy Rehabilitation Program in people with Hip Developmental Dysplasia, run by Jouf University.
Trial summary
One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation [1]. Read more about this study
- Who is it for?
- Ages 9 months to 10 years
- Conditions the study is for
- Hip Developmental Dysplasia
- What is being tested?
- Cross- legged sitting position and Physical Therapy Rehabilitation Program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 16 participants
- Where
- No sites listed yet
- Study dates
- 5 Jun 2025to 30 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 9 months to 10 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- age group from 9 months to 10 years old
- all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
- participants should be healthy in general
Who cannot join
- Any participant with a history of neurological disorders, lower extremities previous surgical intervention, lower limb deformities, flat feet or high body mass index will be excluded from this study
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effect of Engaging the Cross-legged Sitting in Rehabilitation Among Patients With Unilateral Hip Developmental Dysplasia According to Gait Parameters, Foot Pressure and Muscular Electrical Activity.
One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation [1]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity [3]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program [4]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints [5].
While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without.
Read more
To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern.
No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards.
The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all.
Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.
- Conditions
- Hip Developmental Dysplasia
- Being tested
- Cross- legged sitting position, Physical Therapy Rehabilitation Program
- Keywords
- Rehabilitation, Gait, Foot pressure, Hip Developmental Dysplasia
- Medical subject headings
- Developmental Dysplasia of the Hip
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cross- legged sitting positionOther
CLS in which the legs were crossed with hip and knee joints flexed
Physical Therapy Rehabilitation ProgramOther
Strengthening Exercises Stretching Exercises Range of Motion Exercises
| Study group | Role | What they receive |
|---|---|---|
| DDH kids who participated in rehabilitation programs with CLS | Experimental | The study sample includes kids with DDH who participated in rehabilitation programs with CLS. Receives: Other: Cross- legged sitting position; Other: Physical Therapy Rehabilitation Program |
| DDH kids who participated in usual rehabilitation programs without CLS | Active comparator | The study sample includes kids with DDH who participated in rehabilitation programs without CLS. Receives: Other: Physical Therapy Rehabilitation Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gait Temporospatial Parameters
Cadence will be measured by Gait Rite
Measured: 3 months
Muscle Electrical Activity
Muscle Electrical Activity will be measured by Electromygraphy
Measured: 3 months
Secondary outcomes (1)
Foot Pressure
Average pressure will be measured using the foot pressure system
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2025
- Study start5 Jun 2025 (estimated)
- Primary completion30 Dec 2025 (estimated)
- Study completion30 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Developmental DysplasiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 16 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Jouf University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hadeel Saad Alsirhani, Jouf University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07002840
- Sponsor's protocol ID
- HAPO-13-S-(001)-(7371)
- Status last verified
- Apr 2025
- First submitted
- 7 May 2025
- Last updated
- 4 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Engaging the Cross-legged Sitting in Rehabilitation Among Patients With Unilateral Hip Developmental Dysplasia According to Gait Parameters, Foot Pressure and Muscular Electrical Activity.
- ClinicalTrials.gov ID
- NCT07002840
- Acronym / sponsor ID
- HAPO-13-S-(001)-(7371)
- Conditions
- Hip Developmental Dysplasia
- Keywords
- Rehabilitation, Gait, Foot pressure, Hip Developmental Dysplasia
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 16 participants (estimated)
- Lead sponsor
- Jouf UniversityUniversity, hospital or other
- Study start
- 5 Jun 2025 (estimated)
- Primary completion
- 30 Dec 2025 (estimated)
- Study completion
- 30 Dec 2025 (estimated)
- First posted
- 4 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation [1]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity [3]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program [4]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints [5].
While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without.
To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern.
No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards.
The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all.
Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| DDH kids who participated in rehabilitation programs with CLS | Experimental | Other: Cross- legged sitting position, Other: Physical Therapy Rehabilitation ProgramThe study sample includes kids with DDH who participated in rehabilitation programs with CLS. |
| DDH kids who participated in usual rehabilitation programs without CLS | Active comparator | Other: Physical Therapy Rehabilitation ProgramThe study sample includes kids with DDH who participated in rehabilitation programs without CLS. |
Who may qualify
- Ages
- 9 months to 10 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- age group from 9 months to 10 years old
- all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
- participants should be healthy in general
Key exclusion criteria (1 listed)
- Any participant with a history of neurological disorders, lower extremities previous surgical intervention, lower limb deformities, flat feet or high body mass index will be excluded from this study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cross- legged sitting positionCLS in which the legs were crossed with hip and knee joints flexed | Other | DDH kids who participated in rehabilitation programs with CLS |
| Physical Therapy Rehabilitation ProgramStrengthening Exercises Stretching Exercises Range of Motion Exercises | Other | DDH kids who participated in rehabilitation programs with CLS, DDH kids who participated in usual rehabilitation programs without CLS |
Primary outcome
Gait Temporospatial Parameters
Time frame: 3 months
Cadence will be measured by Gait Rite
Muscle Electrical Activity
Time frame: 3 months
Muscle Electrical Activity will be measured by Electromygraphy
1 secondary outcome
Foot Pressure
Time frame: 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Hip Developmental Dysplasia
Not yet recruitingObservational study
3D-Printed Pelvic Models for Planning Complex Total Hip Arthroplasty
Developmental Dysplasia of the Hip, Acetabular Bone Loss
Active, not recruitingObservational study
The Medacta Quadra-P Anteverted Study
Arthrosis, Traumatic Arthritis
RecruitingObservational study
The Medacta International SMS Post-Marketing Surveillance Study
Arthrosis, Traumatic Arthritis
Active, not recruitingObservational study
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Primary Osteoarthritis, Secondary Osteoarthritis
RecruitingObservational study
Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System
Arthritis (Hip), Hip Dysplasia, Congenital
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Cross- legged sitting position and Physical Therapy Rehabilitation Program in people with Hip Developmental Dysplasia, run by Jouf University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hadeel Alsirhani, PhD (+966556256464, hsalserhany@ju.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gait Temporospatial Parameters (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2025.